A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants

NCT06086626 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Gram-Negative Bacterial Infections

Interventions

DRUG: Cefiderocol
DRUG: Standard of Care

Sponsor

Shionogi